LRP5 and colorectal carcinoma: Taken together, these results illustrate that silencing of LRP5 promotes the sensitivity of CRC cells to chemotherapeutic agent and its induced cell apoptosis, and targeting LRP5 could be a valuable strategy for CRC treatment.